1 unchanged sentence
Rule 10b5-1 Trading Arrangements
−Removed: There were no contracts, instructions or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), nor were there any non-Rule 10b5-1 trading arrangements, entered into or terminated by our directors and officers (as defined under Rule 16b-1(f) of the Exchange Act) during the quarter ended September 30, 2023.
+Added: The following table describes contracts, instructions, or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into during the quarter ended March 30, 2024.
+Added: There were no non-Rule 10b5-1 trading arrangements entered into or terminated during the quarter ended March 30, 2024.
+Added: Name and Title of Director or Officer Date of Adoption of Arrangement Duration of the Arrangement Aggregate Number of Securities to be Purchased or Sold Pursuant to the Arrangement
+Added: Matthew Johnson
+Added: President and Chief Executive Officer
+Added: February 29, 2024 (1)
+Added: Expires February 14, 2025 8,443
+Added: Nina Richardson
+Added: February 12, 2024 Expires February 18, 2025 600
+Added: (1) The plan was originally adopted by Mr.
+Added: Johnson on February 15, 2024 and provided for the sale of up to 15,804 shares of our common stock upon vesting of outstanding equity awards.
+Added: After consideration of the Company’s stock ownership guidelines, the plan was amended on February 29, 2024 to reduce the number of shares that may be sold to 8,443 .
The following exhibits are filed as part of this report:
8 unchanged sentences
4.1* Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement).
−Removed: Fifth Amendment to Credit Agreement, dated June 30, 2023, by and among Silicon Laboratories Inc., the subsidiaries of the borrower identified therein, Wells Fargo Bank, National Association and the lenders party thereto.
−Removed: (filed as Exhibit 10.1 to the Form 8-K filed on July 3, 2023).
+Added: 10.1* Silicon Laboratories Inc.
+Added: 2024 Bonus Plan (filed as Exhibit 10.1 to the Form 10-K filed on January 31, 2024.
31.1 Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
1 unchanged sentence
32.1** Certification as required by Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema Document
+Added: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
+Added: ______________________________________________
* Incorporated herein by reference to the indicated filing.
+Added: ** Furnished herewith.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SILICON LABORATORIES INC.
−Removed: November 1, 2023
+Added: April 24, 2024 /s/ R.
Matthew Johnson
3 unchanged sentences
(Principal Executive Officer)
−Removed: November 1, 2023
−Removed: Senior Vice President and
−Removed: Chief Financial Officer
−Removed: (Principal Financial Officer)
−Removed: November 1, 2023
−Removed: Chief Accounting Officer
−Removed: (Principal Accounting Officer)
+Added: April 24, 2024 /s/ Mark D.
+Added: Interim Chief Financial Officer
+Added: (Principal Financial Officer and Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.